In randomized controlled trials, there are two treatment alternatives presently viewed as the standard of treatment in Guillain-Barré syndrome (GBS). These consist of possibly intravenous immunoglobulin (IVIG) or https://ksnr.org.in/guillain-barre-syndrome/